Pharmacovigilance Global Market Report 2025

Global Pharmacovigilance Market Report 2025

Pharmacovigilance Global Market Report 2025 – By Type (Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining), By Service Provider (In-House, Contract Outsourcing), By Process Flow (Case Data Management, Signal Detection, Risk Management System), By Clinical Trial Phases (Preclinical, Phase I, Phase II, Phase III, Phase IV), By End User (Hospitals, Pharmaceutical Companies, Other End Users) – Market Size, Trends, And Global Forecast 2025-2034

Name: Pharmacovigilance Global Market Report 2025
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Pharmacovigilance Global Market Report 2025

Report Price : $4490.00 | Pages : 200 | Published : January 2025 | Delivery Time: 2-3 business days Info | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Pharmacovigilance Global Market Report 2025

Proud Members Of

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

What Is Covered Under Pharmacovigilance Market?

Pharmacovigilance refers to the science and practices involved in the identification, evaluation, comprehension, and mitigation of side effects and other medical/vaccination-related issues. It is used to determine whether a drug's advantages outweigh its hazards, and IT doesn't end once the drugs are approved.

The main types of pharmacovigilance are spontaneous reporting, intensified ADR reporting, targeted spontaneous reporting, cohort event monitoring, and EHR mining. Spontaneous reporting is by nature a passive approach to pharmacovigilance, relying entirely on the motivation of individuals to report suspected adverse drug reactions to local or national pharmacovigilance centers. The different process flows include case data management, signal detection, and risk management systems. The various service providers are in-house and contract to outsource and involve several clinical trial phases such as preclinical, phase I, phase II, phase II, and phase IV. These services are used by several end-users, including hospitals, Pharmaceutical companies, and others.

Pharmacovigilance Market Size and growth rate 2025 to 2029: Graph

What Is The Pharmacovigilance Market Size 2025 And Growth Rate?

The pharmacovigilance market size has grown rapidly in recent years. It will grow from $8.58 billion in 2024 to $9.73 billion in 2025 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to the increasing incidence of adverse drug reactions (ADRs), the increasing research and development (R&D) activities, the growing drug development rates, the increasing focus on personalized medicine, and the rising prevalence of chronic diseases.

What Is The Pharmacovigilance Market Growth Forecast?

The pharmacovigilance market size is expected to see rapid growth in the next few years. It will grow to $15.83 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to the rising healthcare expenditure, the increasing government support and the aging population. Major trends in the forecast period include increasing investments, use of artificial intelligence, use of innovative platforms, use of innovative cloud-based systems, and strategic mergers and acquisitions.

Book your 30 minutes free consultation with our research experts

How Is The Pharmacovigilance Market Segmented?

The pharmacovigilance market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining

2) By Service Provider: In-House, Contract Outsourcing

3) By Process Flow: Case Data Management, Signal Detection, Risk Management System

4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV

5) By End User: Hospitals, Pharmaceutical Companies, Other End Users

Subsegments:

1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals

2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies

3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs

4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies

5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems

What Is Driving The Pharmacovigilance Market? Research And Development Drive Growth In The Pharmacovigilance Market

The increasing research and development activities will drive the pharmacovigilance market. By investing in R&D, pharmaceutical companies can develop new and innovative drugs with improved safety profiles. Rigorous preclinical and clinical testing during the drug development process enables early identification of potential safety concerns, allowing for appropriate risk mitigation strategies to be implemented. Additionally, R&D efforts contribute to the advancement of technologies for adverse event monitoring, data analysis, and signal detection, facilitating the early detection of adverse drug reactions in the post-marketing phase. For instance, in February 2024, according to Llywodraeth Cymru Welsh Government, a UK-based government agency, in 2022 Wales invested £1.0 billion ($1.25 billion) in Business Expenditure on Research and Development (BERD), accounting for 1.9% of the total UK expenditure in this area. Therefore, the increasing research and development activities supported the growth of the pharmacovigilance market.

What Is Driving The Pharmacovigilance Market? Increased Healthcare Expenditure Fuels Growth In The Pharmacovigilance Market

The rising healthcare expenditure will drive the growth of the pharmacovigilance market in the forecast period. With increased funding, healthcare systems can invest in advanced technologies, data analytics, and dedicated teams of experts to efficiently identify and assess adverse drug reactions. Additionally, higher healthcare spending allows for better training and education of healthcare professionals on pharmacovigilance practices, ensuring timely reporting and analysis of potential drug-related issues. For instance, in June 2024, According to The King's Fund, a UK-based non-profit organization, in 2022 the UK allocated 11.3% of its GDP to health, slightly exceeding the average for similar countries. This marked an increase from the pre-Covid-19 pandemic level of 9.9% of GDP dedicated to healthcare. The rise in expenditure reflects a growing emphasis on health services in response to the pandemic. Overall, this indicates a significant shift in healthcare funding priorities. Thus, the rising healthcare expenditure will propel the growth of the pharmacovigilance market going forward.

Who Are The Major Players In The Global Pharmacovigilance Market?

Major companies operating in the pharmacovigilance market include IQVIA, Cognizant, ICON Plc, Accenture plc, PAREXEL International Corporation., United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, Wuxi Apptec, Simcere Pharmaceutical Group, Lee's Pharmaceutical Holdings, Luye Pharma Group, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Alcon, Secure AI Labs, OmniSol dot Tech, Canna Call Company, Veripad, Prevnos Inc., Lifescient, Inc, BeiGene, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., MSD, Novasyte, Fortrea Holdings Inc, Syneos Health Clinical, Zoetis Inc., Telerx Marketing Inc., Gilead Sciences, Inc., Elanco, Abbott Laboratories, Spimaco, Teva Pharmaceutical Industries Ltd.

What Are The Key Trends Of The Global Pharmacovigilance Market? Pharmacovigilance Market Embraces Artificial Intelligence For Enhanced Efficiency And Safety

Companies in the pharmacovigilance market are focusing on artificial intelligence (AI) to improve efficiency. AI can help improve the efficiency and accuracy of pharmacovigilance activities, ultimately leading to better patient outcomes. By utilizing AI, pharma companies can streamline their processes, improve data management, and accelerate drug discovery, while simultaneously reducing costs and improving safety. For instance, in August 2024, the Government of India launched the Adverse Drug Reaction Monitoring System (ADRMS) software, introduced by the Minister of Health & Family Welfare and Minister of Chemicals and Fertilizers. This pharmacovigilance software facilitates the collection and analysis of adverse events related to medicines and medical devices, making the reporting process easier for both consumers and healthcare professionals. This initiative significantly strengthens India's pharmacovigilance infrastructure by ensuring a more comprehensive capture of safety data and enhancing drug safety monitoring. The ADRMS aims to improve the efficiency of drug safety oversight and compliance with standards, helping position India as a leader in the global pharmaceutical industry.

What Are The Key Trends Of The Global Pharmacovigilance Market? PharmaLex Expands Global Presence And Product Portfolio With New Branch In China

Pharmacovigilance providers are focusing on increasing their investments to expand their product portfolio and geographic presence. For example, in September 2022, the PharmaLex Group, a Germany-based provider of solutions for pharmacovigilance systems and operations, announced the opening of a new branch in Beijing, China. The PharmaLex Beijing team provides global companies bringing medicines to the Chinese market with the comprehensive PharmaLex value proposition for pharmacovigilance, regulatory affairs, development advice, and quality management.

Pharmacovigilance Market Merger And Acquisition: AmerisourceBergen Strengthens Service Offering With Acquisition Of Pharma Lex

In January 2023, AmerisourceBergen, an American drug wholesale company, acquired Pharma Lex for an undisclosed amount. This acquisition is expected to add capabilities to the company's existing service offering, allowing the company to provide pharmaceutical and biotech companies with enhanced support and value across the product lifecycle. Pharma Lex’s Germany-based team provides true end-to-end solutions for pharmacovigilance systems and operations, as well as benefit-risk management services.

Regional Outlook For The Global Pharmacovigilance Market

North America was the largest region in the pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmacovigilance market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

What Defines the Pharmacovigilance Market?

The pharmacovigilance market includes revenues earned by collecting, analyzing, monitoring, and preventing adverse effects in drugs and therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Pharmacovigilance Industry?

The pharmacovigilance market research report is one of a series of new reports from The Business Research Company that provides pharmacovigilance market statistics, including pharmacovigilance industry global market size, regional shares, competitors with a pharmacovigilance market share, detailed pharmacovigilance market segments, market trends, and opportunities, and any further data you may need to thrive in the pharmacovigilance industry. This pharmacovigilance market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Pharmacovigilance Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$9.73 billion
Revenue Forecast In 2034	$15.83 billion
Growth Rate	CAGR of 12.9% from 2024 to 2033
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining 2) By Service Provider: In-House, Contract Outsourcing 3) By Process Flow: Case Data Management, Signal Detection, Risk Management System 4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV 5) By End User: Hospitals, Pharmaceutical Companies, Other End Users Subsegments: 1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals 2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies 3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs 4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies 5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	IQVIA, Cognizant, ICON Plc, Accenture plc, PAREXEL International Corporation., United BioSource LLC, ArisGlobal, Quanticate, Wipro Limited, Linical Americas, Novotech CRO, Wuxi Apptec, Simcere Pharmaceutical Group, Lee's Pharmaceutical Holdings, Luye Pharma Group, EXTEDO, Arriello, PrimeVigilance, Axios International, C3i Solutions, Alcon, Secure AI Labs, OmniSol dot Tech, Canna Call Company, Veripad, Prevnos Inc., Lifescient, Inc, BeiGene, QuintilesIMS, Labcorp Drug Development, Pharmaceutical Product Development Inc., PRA Health Sciences, Synowledge LLC, RAPAhub, illuminate health, Invenio Medical, ClinChoice Inc., MSD, Novasyte, Fortrea Holdings Inc, Syneos Health Clinical, Zoetis Inc., Telerx Marketing Inc., Gilead Sciences, Inc., Elanco, Abbott Laboratories, Spimaco, Teva Pharmaceutical Industries Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Pharmacovigilance Market Characteristics

3. Pharmacovigilance Market Trends And Strategies

4. Pharmacovigilance Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Pharmacovigilance Growth Analysis And Strategic Analysis Framework

5.1. Global Pharmacovigilance PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Pharmacovigilance Market Growth Rate Analysis

5.4. Global Pharmacovigilance Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Pharmacovigilance Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Pharmacovigilance Total Addressable Market (TAM)

6. Pharmacovigilance Market Segmentation

6.1. Global Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Spontaneous Reporting

Intensified ADR Reporting

Targeted Spontaneous Reporting

Cohort Event Monitoring

EHR Mining

6.2. Global Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

In-House

Contract Outsourcing

6.3. Global Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Case Data Management

Signal Detection

Risk Management System

6.4. Global Pharmacovigilance Market, Segmentation By Clinical Trial Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Preclinical

Phase I

Phase II

Phase III

Phase IV

6.5. Global Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Pharmaceutical Companies

Other End Users

6.6. Global Pharmacovigilance Market, Sub-Segmentation Of Spontaneous Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Individual Case Safety Reports (ICSRs)

Voluntary Reporting Systems

Case Reports From Healthcare Professionals

6.7. Global Pharmacovigilance Market, Sub-Segmentation Of Intensified ADR Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Active Surveillance Programs

Enhanced Monitoring In Clinical Trials

Risk Minimization Strategies

6.8. Global Pharmacovigilance Market, Sub-Segmentation Of Targeted Spontaneous Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Reporting For Specific Drug Classes

Condition-Specific Reporting

Focused Surveillance Programs

6.9. Global Pharmacovigilance Market, Sub-Segmentation Of Cohort Event Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prospective Cohort Studies

Retrospective Cohort Studies

Longitudinal Studies

6.10. Global Pharmacovigilance Market, Sub-Segmentation Of EHR Mining, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Data Extraction From Electronic Health Records

Signal Detection Through EHR Analysis

Integration Of EHR Data With Pharmacovigilance Systems

7. Pharmacovigilance Market Regional And Country Analysis

7.1. Global Pharmacovigilance Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Pharmacovigilance Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Pharmacovigilance Market

8.1. Asia-Pacific Pharmacovigilance Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Pharmacovigilance Market

9.1. China Pharmacovigilance Market Overview

9.2. China Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Pharmacovigilance Market

10.1. India Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Pharmacovigilance Market

11.1. Japan Pharmacovigilance Market Overview

11.2. Japan Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Pharmacovigilance Market

12.1. Australia Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Pharmacovigilance Market

13.1. Indonesia Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Pharmacovigilance Market

14.1. South Korea Pharmacovigilance Market Overview

14.2. South Korea Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Pharmacovigilance Market

15.1. Western Europe Pharmacovigilance Market Overview

15.2. Western Europe Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Pharmacovigilance Market

16.1. UK Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Pharmacovigilance Market

17.1. Germany Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Pharmacovigilance Market

18.1. France Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Pharmacovigilance Market

19.1. Italy Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Pharmacovigilance Market

20.1. Spain Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Pharmacovigilance Market

21.1. Eastern Europe Pharmacovigilance Market Overview

21.2. Eastern Europe Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Pharmacovigilance Market

22.1. Russia Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Pharmacovigilance Market

23.1. North America Pharmacovigilance Market Overview

23.2. North America Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Pharmacovigilance Market

24.1. USA Pharmacovigilance Market Overview

24.2. USA Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Pharmacovigilance Market

25.1. Canada Pharmacovigilance Market Overview

25.2. Canada Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Pharmacovigilance Market

26.1. South America Pharmacovigilance Market Overview

26.2. South America Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Pharmacovigilance Market

27.1. Brazil Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Pharmacovigilance Market

28.1. Middle East Pharmacovigilance Market Overview

28.2. Middle East Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Pharmacovigilance Market

29.1. Africa Pharmacovigilance Market Overview

29.2. Africa Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Pharmacovigilance Market Competitive Landscape And Company Profiles

30.1. Pharmacovigilance Market Competitive Landscape

30.2. Pharmacovigilance Market Company Profiles

30.2.1. IQVIA Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Cognizant Overview, Products and Services, Strategy and Financial Analysis

30.2.3. ICON Plc Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Accenture plc Overview, Products and Services, Strategy and Financial Analysis

30.2.5. PAREXEL International Corporation. Overview, Products and Services, Strategy and Financial Analysis

31. Pharmacovigilance Market Other Major And Innovative Companies

31.1. United BioSource LLC

31.2. ArisGlobal

31.3. Quanticate

31.4. Wipro Limited

31.5. Linical Americas

31.6. Novotech CRO

31.7. Wuxi Apptec

31.8. Simcere Pharmaceutical Group

31.9. Lee's Pharmaceutical Holdings

31.10. Luye Pharma Group

31.11. EXTEDO

31.12. Arriello

31.13. PrimeVigilance

31.14. Axios International

31.15. C3i Solutions

32. Global Pharmacovigilance Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Pharmacovigilance Market

34. Recent Developments In The Pharmacovigilance Market

35. Pharmacovigilance Market High Potential Countries, Segments and Strategies

35.1 Pharmacovigilance Market In 2029 - Countries Offering Most New Opportunities

35.2 Pharmacovigilance Market In 2029 - Segments Offering Most New Opportunities

35.3 Pharmacovigilance Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Pharmacovigilance Market, Segmentation By Clinical Trial Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Pharmacovigilance Market, Sub-Segmentation Of Spontaneous Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Pharmacovigilance Market, Sub-Segmentation Of Intensified ADR Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Pharmacovigilance Market, Sub-Segmentation Of Targeted Spontaneous Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Global Pharmacovigilance Market, Sub-Segmentation Of Cohort Event Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Global Pharmacovigilance Market, Sub-Segmentation Of EHR Mining, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Global Pharmacovigilance Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: Global Pharmacovigilance Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: Asia-Pacific, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: Asia-Pacific, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: Asia-Pacific, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: China, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: China, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: China, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: India, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: India, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: India, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Japan, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Japan, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Japan, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Australia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Australia, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: Australia, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: Indonesia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: Indonesia, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Indonesia, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: South Korea, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: South Korea, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: South Korea, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: Western Europe, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: Western Europe, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Western Europe, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: UK, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: UK, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: UK, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: Germany, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: Germany, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Germany, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: France, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: France, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: France, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Italy, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Italy, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Italy, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Spain, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Spain, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Spain, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Eastern Europe, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Eastern Europe, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: Eastern Europe, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: Russia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: Russia, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: Russia, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: North America, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: North America, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: North America, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: USA, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: USA, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: USA, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: Canada, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: Canada, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Canada, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: South America, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: South America, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: South America, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Brazil, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Brazil, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Brazil, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Middle East, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Middle East, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Middle East, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 78: Africa, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 79: Africa, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 80: Africa, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 81: IQVIA Financial Performance

Table 82: Cognizant Financial Performance

Table 83: ICON Plc Financial Performance

Table 84: Accenture plc Financial Performance

Table 85: PAREXEL International Corporation. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Pharmacovigilance Market, Segmentation By Clinical Trial Phases, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Pharmacovigilance Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Pharmacovigilance Market, Sub-Segmentation Of Spontaneous Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Pharmacovigilance Market, Sub-Segmentation Of Intensified ADR Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Pharmacovigilance Market, Sub-Segmentation Of Targeted Spontaneous Reporting, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Global Pharmacovigilance Market, Sub-Segmentation Of Cohort Event Monitoring, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Global Pharmacovigilance Market, Sub-Segmentation Of EHR Mining, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Global Pharmacovigilance Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: Global Pharmacovigilance Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: Asia-Pacific, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: Asia-Pacific, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: Asia-Pacific, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: China, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: China, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: China, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: India, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: India, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: India, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Japan, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Japan, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Japan, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Australia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Australia, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: Australia, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: Indonesia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: Indonesia, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Indonesia, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: South Korea, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: South Korea, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: South Korea, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: Western Europe, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: Western Europe, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Western Europe, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: UK, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: UK, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: UK, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: Germany, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: Germany, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Germany, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: France, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: France, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: France, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Italy, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Italy, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Italy, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Spain, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Spain, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Spain, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Eastern Europe, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Eastern Europe, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: Eastern Europe, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: Russia, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: Russia, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: Russia, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: North America, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: North America, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: North America, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: USA, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: USA, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: USA, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: Canada, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: Canada, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Canada, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: South America, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: South America, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: South America, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Brazil, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Brazil, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Brazil, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Middle East, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Middle East, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Middle East, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 78: Africa, Pharmacovigilance Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 79: Africa, Pharmacovigilance Market, Segmentation By Service Provider, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 80: Africa, Pharmacovigilance Market, Segmentation By Process Flow, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 81: IQVIA Financial Performance

Figure 82: Cognizant Financial Performance

Figure 83: ICON Plc Financial Performance

Figure 84: Accenture plc Financial Performance

Figure 85: PAREXEL International Corporation. Financial Performance

How is the Anti-Aging Market Poised for Growth: Trends and Opportunities Through 2034

What’s Driving Growth in the Anticoagulants Market? Insights into Key Trends and Opportunities

Comprehensive Analysis of the Biomarkers Market 2025-2034: Growth Rates, Trends, and Future Opportunities

How Will the Botanical Supplements Market Grow? Key Trends and Opportunities for 2025 and Beyond

Cancer Immunotherapy Market Growth Forecast: Exploring Trends and Opportunities for the Next Decade

Comprehensive Analysis of the Compression Therapy Market 2025-2034: Growth Rates, Trends, and Future Opportunities

Unlocking the Future of the Contraceptives Market: Growth Rate, Key Trends, and Opportunities for 2025-2034

Contract Development Manufacturing Organizations Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities

Pharmaceutical Drugs Global Market Report 2025 – By Type (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Disease Drugs, Vaccine And Therapeutic Nutrients, Minerals), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores, Other Distribution Channels), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Over-The-Counter (OTC) Drugs, Prescription-Based Drugs) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmaceutical Excipients Global Market Report 2025 – By Product (Inorganic Chemicals, Organic Chemicals, Other Products), By Functionality (Fillers And Diluents, Suspending And Viscosity Agents, Coating Agents, Binders, Flavoring Agents And Sweeteners, Disintegrants, Colorants, Lubricants And Glidants, Other Functionalities), By Type Of Formulation (Oral Formulation, Topical Formulation, Parenteral Formulation, Other Formulations) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharma Microbiology Testing Kits Global Market Report 2025 – By Product (Consumables, Equipment), By Test (Endotoxin Testing, Sterility Testing, Microbial Examination, Environmental Monitoring, Other Tests), By End User (Hospitals & Diagnostic Centers, Custom Lab Service Providers, Academic & Research Institutes) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2025 – By Type (Contract Manufacturing Services, Contract Research Services), By Research Phase (Preclinical, Phase I, Phase II, Phase III, Phase IV), By End User (Big Pharmaceutical Companies, Generic Pharmaceutical Companies, Small And Medium-Sized Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmaceutical Sterility Testing Global Market Report 2025 – By Sample (Sterile Drugs, Medical Devices, Biologics and Therapeutics), By Product Type (Instruments, Kits and Reagents, Services), By Type (In- house, Outsourcing), By Test Type (Sterility Testing, Bioburden Testing, Bacterial Endotoxin Testing), By End- User (Compounding Pharmacies, Medical Devices Companies, Pharmaceutical Companies) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmaceutical API Manufacturing Global Market Report 2025 – By Therapy Area (Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, Other Therapeutics Uses), By API Type (Chemical API, Biological API), By Drug Type (Prescription Drugs, Over-The-Counter (OTC) Drugs) – Market Size, Trends, And Global Forecast 2025-2034

View Report

AI In Pharma Global Market Report 2025 – By Technology (Context-Aware Processing, Natural Language Processing, Querying Method, Deep Learning), By Drug Type (Small Molecule, Large Molecules), By Application (Diagnosis, Clinical Trial Research, Drug Discovery, Research and Development, Epidemic Prediction) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Pharmaceutical Packaging Equipment Global Market Report 2025 – By Product (Primary Packaging Equipment, Secondary Packaging Equipment, Labelling And Sterilization Equipment), By Packaging Type (Liquids Packaging Equipment, Solid Packaging Equipment, Semi-Solid Packaging Equipment), By Equipment Type (Blenders, Granulators, Tablet Pressers, Tablet Coating Machine, Allied Machines), By Mode of Administration (Injectable Administration, Topical Administration, Oral Administration) – Market Size, Trends, And Global Forecast 2025-2034

View Report

Frequently Asked Questions

What is the definition of the Pharmacovigilance market?

How will the Pharmacovigilance market drivers and restraints affect the market dynamics? What forces will shape the Pharmacovigilance industry going forward?

The Pharmacovigilance market major growth driver - Research And Development Drive Growth In The Pharmacovigilance Market. For further insights on the Pharmacovigilance market, request a sample here

What is the forecast market size or the forecast market value of the Pharmacovigilance market?

The Pharmacovigilance market size has grown strongly in recent years. The pharmacovigilance market size has grown rapidly in recent years. It will grow from $8.58 billion in 2024 to $9.73 billion in 2025 at a compound annual growth rate (CAGR) of 13.5%. The growth in the historic period can be attributed to the increasing incidence of adverse drug reactions (ADRs), the increasing research and development (R&D) activities, the growing drug development rates, the increasing focus on personalized medicine, and the rising prevalence of chronic diseases. The pharmacovigilance market size is expected to see rapid growth in the next few years. It will grow to $15.83 billion in 2029 at a compound annual growth rate (CAGR) of 12.9%. The growth in the forecast period can be attributed to the rising healthcare expenditure, the increasing government support and the aging population. Major trends in the forecast period include increasing investments, use of artificial intelligence, use of innovative platforms, use of innovative cloud-based systems, and strategic mergers and acquisitions. For further insights on the Pharmacovigilance market, request a sample here

How is the Pharmacovigilance market segmented?

The pharmacovigilance market covered in this report is segmented –
1) By Type: Spontaneous Reporting, Intensified ADR Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, EHR Mining
2) By Service Provider: In-House, Contract Outsourcing
3) By Process Flow: Case Data Management, Signal Detection, Risk Management System
4) By Clinical Trial Phases: Preclinical, Phase I, Phase II, Phase III, Phase IV
5) By End User: Hospitals, Pharmaceutical Companies, Other End Users Subsegments:
1) By Spontaneous Reporting: Individual Case Safety Reports (ICSRs), Voluntary Reporting Systems, Case Reports From Healthcare Professionals
2) By Intensified ADR Reporting: Active Surveillance Programs, Enhanced Monitoring In Clinical Trials, Risk Minimization Strategies
3) By Targeted Spontaneous Reporting: Reporting For Specific Drug Classes, Condition-Specific Reporting, Focused Surveillance Programs
4) By Cohort Event Monitoring: Prospective Cohort Studies, Retrospective Cohort Studies, Longitudinal Studies
5) By EHR Mining: Data Extraction From Electronic Health Records, Signal Detection Through EHR Analysis, Integration Of EHR Data With Pharmacovigilance Systems For further insights on the Pharmacovigilance market, request a sample here

Which region has the largest share of the Pharmacovigilance market? What are the other regions covered in the report?

North America was the largest region in the pharmacovigilance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast region. The regions covered in the pharmacovigilance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the Pharmacovigilance market, request a sample here.

Who are the major players in the Pharmacovigilance market?

What are the key trends in the Pharmacovigilance market?

Major trends in the Pharmacovigilance market include Pharmacovigilance Market Embraces Artificial Intelligence For Enhanced Efficiency And Safety. For further insights on the Pharmacovigilance market, request a sample here.

What are the major opportunities in the Pharmacovigilance market? What are the strategies for the Pharmacovigilance market?

For detailed insights on the major opportunities and strategies in the Pharmacovigilance market, request a sample here.

How does the Pharmacovigilance market relate to the overall economy and other similar markets?

For detailed insights on Pharmacovigilance's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the Pharmacovigilance industry?

For detailed insights on the mergers and acquisitions in the Pharmacovigilance industry, request a sample here.

What are the key dynamics influencing the Pharmacovigilance market growth? SWOT analysis of the Pharmacovigilance market.

For detailed insights on the key dynamics influencing the Pharmacovigilance market growth and SWOT analysis of the Pharmacovigilance industry, request a sample here.